The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Esmya



Gedeon Richter PlcEU/1/12/750/001

Main Information

Trade NameEsmya
Active SubstancesUlipristal acetate
Dosage FormTablet
Licence HolderGedeon Richter Plc
Licence NumberEU/1/12/750/001

Group Information

ATC CodeG03XB Progesterone receptor modulators
G03XB02 ulipristal

Status

License statusAuthorised
Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusNot applicable
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Educational Materials - HCP

Educational Materials - Patient

« Back